Mala Murthy - 30 May 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jun 2025, 17:36:42 UTC
Prior SEC filing
12 May 2025
Next SEC filing
03 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Mala Murthy filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Jun 2025.

Key facts

  • This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
  • 11 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 03 Jun 2025, 17:36.

Change

  • Previous filing in this sequence was filed on 12 May 2025.
  • Current net transaction value: -$95,052.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001780955 Primary reporting owner

Murthy Mala

Relationship
CHIEF FINANCIAL OFFICER
Address
C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date
03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,641
Change %
+2.2%
Price
Shares after
124,108
Date
30 May 2025
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,044
Change %
+1.6%
Price
Shares after
126,152
Date
30 May 2025
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+7,751
Change %
+6.1%
Price
Shares after
133,903
Date
30 May 2025
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+9,233
Change %
+6.9%
Price
Shares after
143,136
Date
30 May 2025
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,163
Change %
+2.2%
Price
Shares after
146,299
Date
30 May 2025
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Sale

Transaction value
$95,052
Shares
-13,856
Change %
-9.5%
Price
$6.86
Shares after
132,443
Date
02 Jun 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
$0
Shares
-2,641
Change %
-25%
Price
$0.000000
Shares after
7,926
Date
30 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,641
Exercise price
Footnotes
F3, F4
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,044
Change %
-100%
Price
$0.000000
Shares after
0
Date
30 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,044
Exercise price
Footnotes
F1, F5
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-7,751
Change %
-25%
Price
$0.000000
Shares after
23,253
Date
30 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,751
Exercise price
Footnotes
F1, F6
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-9,233
Change %
-12%
Price
$0.000000
Shares after
64,634
Date
30 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,233
Exercise price
Footnotes
F1, F7
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-3,163
Change %
-12%
Price
$0.000000
Shares after
22,142
Date
30 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,163
Exercise price
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Footnote F3

Each performance stock unit represents a contingent right to receive one share of TDOC common stock.

Footnote F4

The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F5

On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F6

On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F7

One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .